Search
for
Sort by
Research 61–90 of 71
- LB1101 Evaluating the cardiovascular safety of low-dose oral minoxidil in patients with non-scarring alopecia: A retrospective cohort study
- LB919 Increased risk of skin cancer and other malignancies in patients with cutaneous lupus erythematous
- 266 Exploring the bidirectional impact of gastrointestinal and rosacea treatments on comorbid patients: A multi-center health records analysis
- MP74-11 TRENDS IN THE PHARMACOTHERAPY OF NOCTURIA, 2016-2021: ANALYSIS OF A LARGE MULTI-INSTITUTIONAL RESEARCH NETWORK
- Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?
- 76626 Adjunctive Combined Regenerative Technique (CRT) vs Oral Minoxidil Alone for Androgenetic Alopecia: A Six-Month Retrospective Study
- 74126 GLP-1RA Medications and Alopecia: Evaluating Risk Across Diabetic and Non-Diabetic Populations
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations
- 76976 Association of Depression with Finasteride Stratified by Dosage and Diagnosis: A Retrospective Cohort Study Using the TriNetX Database
- The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study
- Increased risk of telogen effluvium with tirzepatide compared to other weight-loss medications: a retrospective cohort TriNetX database study
- 53028 Semaglutide and Hair Loss: A Real-World Analysis
- When hair dig into the brain, JAKi , may help!
- No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study
- Association of Janus kinase inhibitors with reduced depression in alopecia areata
- Alopecia Areata Associated with Dupilumab: National Database Study
- No elevated risk for osteoporosis or osteopenia among women with androgenetic or frontal fribrosing alopecia treated with 5-alpha reductase inhibitors: A retrospective TriNetX cohort study
- 0250 Systemic therapy associates with a lower incidence of male infertility among psoriasis patients
- Low serum testosterone is associated with an increased risk of first-time renal calculi in men without testosterone replacement therapy
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Directional Association Between Irritable Bowel Syndrome and Dermatological Disease: A Large-Scale Retrospective Study
- Celiac disease associated with alopecia areata: A multicenter case-control study
- IP28-24 RISK OF ERECTILE DYSFUNCTION AMONG REPRODUCTIVE-AGED MEN FOLLOWING LOW-DOSE FINASTERIDE USE FOR ANDROGENETIC ALOPECIA: A PROPENSITY-MATCHED COHORT STUDY
- 0441 Systemic autoimmune comorbidity in alopecia totalis and universalis compared with patchy alopecia areata: A retrospective cohort study
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Increased Incidence and Risk of Hair Loss with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Multicentre Cohort Study
- Menopause and Common Dermatoses: A Systematic Review